BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 16501077)

  • 1. Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2.
    Brzózka K; Finke S; Conzelmann KK
    J Virol; 2006 Mar; 80(6):2675-83. PubMed ID: 16501077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3.
    Brzózka K; Finke S; Conzelmann KK
    J Virol; 2005 Jun; 79(12):7673-81. PubMed ID: 15919920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
    Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
    Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity.
    Rieder M; Brzózka K; Pfaller CK; Cox JH; Stitz L; Conzelmann KK
    J Virol; 2011 Jan; 85(2):842-52. PubMed ID: 21084487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
    Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
    J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis of the Inhibition of STAT1 Activity by Sendai Virus C Protein.
    Oda K; Matoba Y; Irie T; Kawabata R; Fukushi M; Sugiyama M; Sakaguchi T
    J Virol; 2015 Nov; 89(22):11487-99. PubMed ID: 26339056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nipah and Hendra Virus Nucleoproteins Inhibit Nuclear Accumulation of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT2 by Interfering with Their Complex Formation.
    Sugai A; Sato H; Takayama I; Yoneda M; Kai C
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation.
    Rodriguez JJ; Parisien JP; Horvath CM
    J Virol; 2002 Nov; 76(22):11476-83. PubMed ID: 12388709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1.
    Vidy A; El Bougrini J; Chelbi-Alix MK; Blondel D
    J Virol; 2007 Apr; 81(8):4255-63. PubMed ID: 17287281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling.
    Gotoh B; Takeuchi K; Komatsu T; Yokoo J
    J Virol; 2003 Mar; 77(6):3360-70. PubMed ID: 12610111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
    Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of IFN-alpha/beta signaling by two discrete peptides within measles virus V protein that specifically bind STAT1 and STAT2.
    Caignard G; Bouraï M; Jacob Y; ; Tangy F; Vidalain PO
    Virology; 2009 Jan; 383(1):112-20. PubMed ID: 19007958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK-STAT signaling pathways are activated in the brain following reovirus infection.
    Goody RJ; Beckham JD; Rubtsova K; Tyler KL
    J Neurovirol; 2007 Aug; 13(4):373-83. PubMed ID: 17849321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
    Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
    Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive STAT1 tyrosine phosphorylation in U937 monocytes overexpressing the TYK2 protein tyrosine kinase does not induce gene transcription.
    Eilers A; Kanda K; Klose B; Krolewski J; Decker T
    Cell Growth Differ; 1996 Jun; 7(6):833-40. PubMed ID: 8780896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
    Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
    J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired type I IFN-induced Jak/STAT signaling in FA-C cells and abnormal CD4+ Th cell subsets in Fancc-/- mice.
    Fagerlie SR; Koretsky T; Torok-Storb B; Bagby GC
    J Immunol; 2004 Sep; 173(6):3863-70. PubMed ID: 15356134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.
    Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE
    Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.